Blocking PRMT5 might force resistant brain-tumor cells into senescence, study suggests
A new study suggests that blocking an enzyme called PRMT5 in tumor cells could be a promising new strategy for the treatment of glioblastoma (GB), the most aggressive and lethal form of brain cancer.
Jun 13, 2016
0
35